$1.8B
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | CLDX Celldex Therapeutics Inc New | 5.3M | −8.9% | $198M | 10.9% |
| 2 | SNDX Syndax Pharmaceuticals Inc | 8.1M | +0.0% | $176M | 9.7% |
| 3 | PCVX Vaxcyte Inc | 2.9M | +0.0% | $170M | 9.4% |
| 4 | COGT Cogent Biosciences Inc | 3.7M | −9.2% | $142M | 7.8% |
| 5 | VERA Vera Therapeutics Inc | 2.9M | −15.0% | $124M | 6.9% |
| 6 | VRDN Viridian Therapeutics Inc | 6.5M | +175.6% | $119M | 6.6% |
| 7 | TVTX Travere Therapeutics Inc | 2.0M | +27.5% | $114M | 6.3% |
| 8 | BEAM Beam Therapeutics Inc | 2.8M | −22.9% | $97M | 5.4% |
| 9 | URGN Urogen Pharma Ltd | 2.4M | +8.3% | $90M | 5.0% |
| 10 | LEGN Legend Biotech Corp | 3.0M | +90.4% | $87M | 4.8% |
| 11 | CTMX Cytomx Therapeutics Inc. | 21.7M | +44.6% | $81M | 4.5% |
| 12 | RLAY Relay Therapeutics Inc | 3.3M | +131.7% | $62M | 3.4% |
| 13 | CGEM Cullinan Therapeutics Inc | 3.1M | +0.0% | $57M | 3.1% |
| 14 | MBX Mbx Biosciences Inc | 934,799 | +0.0% | $52M | 2.9% |
| 15 | IMCR Immunocore Hldgs Plc | 1.4M | +55.4% | $44M | 2.4% |
| 16 | NRIX Nurix Therapeutics Inc | 1.2M | +0.0% | $29M | 1.6% |
| 17 | STRO Sutro Biopharma Inc | 872,558 | +0.0% | $29M | 1.6% |
| 18 | BCRX Biocryst Pharmaceuticals Inc | 2.5M | −55.6% | $25M | 1.4% |
| 19 | PHVS Pharvaris N V | 661,795 | +3.3% | $23M | 1.3% |
| 20 | SMMT Summit Therapeutics Inc | 1.2M | — | $17M | 1.0% |
| 21 | PRLD Prelude Therapeutics Inc | 2.4M | +51.6% | $13M | 0.7% |
| 22 | INSM Insmed Inc | 100,000 | — | $11M | 0.6% |
| 23 | BNR Burning Rock Biotech Ltd | 1.2M | +0.9% | $11M | 0.6% |
| 24 | GERN Geron Corp | 6.8M | +0.0% | $9M | 0.5% |
| 25 | AMARIN CORP PLC Amarin Corp Plc | 532,982 | +12.8% | $8M | 0.5% |
| 26 | ALEC Alector Inc | 3.8M | +90.4% | $8M | 0.4% |
| 27 | PBLS Parabilis Medicines Inc | 250,000 | — | $7M | 0.4% |
| 28 | CRBU Caribou Biosciences Inc | 2.5M | +0.0% | $4M | 0.2% |
| 29 | PROQR THRAPEUTICS N V Proqr Thrapeutics N V | 1.6M | +0.0% | $3M | 0.2% |
| 30 | CADL Candel Therapeutics Inc | 96,741 | −51.6% | $996,432 | 0.1% |
| 31 | ENGN Engene Therapeutics Inc | 457,855 | — | $792,089 | 0.0% |
| 32 | TRAW Traws Pharma Inc | 84,400 | — | $71,175 | 0.0% |